Eventos adversos en 1395 infusiones con diferentes preparados de gammaglobulina intravenosa
Malbrán, Alejandro; Larrauri, Blas; Juri, María Cecilia; Fernández Romero, Diego S..
Medicina (B.Aires)
; 73(5): 433-437, oct. 2013. tab
Artículo en Español | BINACIS | ID: bin-130313
Documentos relacionados
Psoriasiform dermatitis following intravenous immunoglobulin therapy: A case series.
[Adverse events in 1395 infusions with different intravenous gammaglobulin products].
Intravenous immunoglobulin alteration in response to adverse reactions in neurological conditions: A retrospective cohort study.
Trial of Intravenous Immune Globulin in Dermatomyositis.
Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations.
A retrospective analysis of haemolytic reactions to intravenous immunoglobulin using data from the Transfusion-Transmitted Injuries Surveillance System (Ontario).
Intravenous immunoglobulin in kidney transplantation: Mechanisms of action, clinical applications, adverse effects, and hyperimmune globulin.
Intravenous immunoglobulin for treatment of hospitalized COVID-19 patients: an evidence mapping and meta-analysis.
Treatments for multi-system inflammatory syndrome in children - discharge, fever, and second-line therapies.
Intravenous immunoglobulin (IVIG) in the vanguard therapy of Systemic Sclerosis.